Filing
Spy
Filing
Spy
Home
About
EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103
Healthcare
US
1 holder
Ownership
Activity
Recent Activity
Show $
2021Q2
1 sell
Maverick Capital
EXIT
-331 shares
Maverick Capital
EXIT
-331 shares
Loading more activity...
EDIT — Editas Medicine Inc - FilingSpy